🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

20 mg (125% DV)
✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 20mg UL 35mg
Slimvance Patented Blend
450 mg
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 200mg UL 400mg
📊 Market median: 600.0mg (321 products) 📚 5 studies — no high-quality reviews
This product: 100mg
Capsimax fruit extract
33.34 mg
Piperine
5 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Hydroxypropylcellulose Calcium Silicate Magnesium Stearate Titanium Dioxide Artificial Colors

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take two capsules twice daily. For best results, take one serving in the morning and then another serving 30-60 minutes prior to exercise approximately 4-6 hours later. Do not exceed recommended dose per day. Do not combine with other products containing stimulants, such as caffeine. Do not take before bedtime.

⚠️ Warnings & Precautions

Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Discontinue use two weeks prior to surgery.

Keep out of reach of children.

🧪 Formulation Notes

No starch, no artificial flavors, sodium free, no wheat, gluten free, no corn, no soy, no dairy.

Clinically shown to help you: Lose weight Lose inches Reshape your body by targeting common trouble areas Burn more calories and increase metabolism Achieve transformational weight loss in just 16 weeks Use in conjunction with the diet and exercise plan available at www.slimvance.com/plan. Thermogenic 12X more calorie burn 6X more weight loss 3X hip & waist reduction

Additional Information

Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

A randomized clinical study of 140 healthy overweight people compared the use of Slimvance in conjunction with an 1800 calorie diet and walking plan to a placebo with the same diet and walking plan. Those on Slimvance lost almost 10 more pounds (-11.81 pounds vs. -1.91 pounds), lost over an inch more around the hips (-1.76 inches vs. -0.48 inches) and lost over an inch more around the waist (-2.12 inches vs. -0.68 inches) than the placebo group after 16 weeks. In a double-blind, randomized, placebo-controlled crossover study, 25 subjects exercised on a treadmill on two occasions. On once occasion, the subjects took the thermogenic blend 60 minutes before exercise, and on the second occasion, they took a placebo. When the subjects took the thermogenic blend, they burned three times more calories before, 3% more calories during and 12 times more calories for up to one hour after exercise compared to when they took the placebo.

Store in a cool, dry place.

Product Details

DSLD Entry Date 2020-05-22
Product Type Other Combinations
Form Capsule
DSLD ID 219891
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →